Armata Pharmaceuticals (ARMP) Operating Expenses (2016 - 2026)
Quarterly results put Operating Expenses at $9.6 million for Q1 2026, up 10.27% from a year ago — trailing twelve months through Mar 2026 was $42.4 million (down 5.92% YoY), and the annual figure for FY2025 was $41.5 million, down 12.75%.
Armata Pharmaceuticals has reported Operating Expenses over the past 14 years, most recently at $9.6 million for Q1 2026.
- Operating Expenses reached $9.6 million in Q1 2026 per ARMP's latest filing, down from $14.9 million in the prior quarter.
- Across five years, Operating Expenses topped out at $14.9 million in Q4 2025 and bottomed at $8.7 million in Q1 2025.
- Median Operating Expenses over the past 5 years was $11.1 million (2023), compared with a mean of $11.0 million.
- The largest annual shift saw Operating Expenses skyrocketed 61.7% in 2022 before it fell 29.81% in 2025.
- Over 5 years, Operating Expenses stood at $11.4 million in 2022, then fell by 2.39% to $11.1 million in 2023, then grew by 6.01% to $11.8 million in 2024, then rose by 26.62% to $14.9 million in 2025, then tumbled by 35.78% to $9.6 million in 2026.
- Business Quant data shows Operating Expenses for ARMP at $9.6 million in Q1 2026, $14.9 million in Q4 2025, and $8.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 2.97 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 4.33 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -138.30 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 15.76 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.85 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.96 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -3.82 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 898.54 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 9.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.57 Mn |
| Dec 31, 2025 | 14.91 Mn |
| Sep 30, 2025 | 8.94 Mn |
| Jun 30, 2025 | 9.01 Mn |
| Mar 31, 2025 | 8.68 Mn |
| Dec 31, 2024 | 11.77 Mn |
| Sep 30, 2024 | 12.73 Mn |
| Jun 30, 2024 | 11.91 Mn |
| Mar 31, 2024 | 11.19 Mn |
| Dec 31, 2023 | 11.11 Mn |
| Sep 30, 2023 | 11.56 Mn |
| Jun 30, 2023 | 10.61 Mn |
| Mar 31, 2023 | 12.14 Mn |
| Dec 31, 2022 | 11.38 Mn |
| Sep 30, 2022 | 9.96 Mn |
| Jun 30, 2022 | 11.10 Mn |
| Mar 31, 2022 | 10.01 Mn |
| Dec 31, 2021 | 7.04 Mn |
| Sep 30, 2021 | 7.39 Mn |
| Jun 30, 2021 | 7.36 Mn |
| Mar 31, 2021 | 6.50 Mn |
| Dec 31, 2020 | 6.96 Mn |
| Sep 30, 2020 | 5.91 Mn |
| Jun 30, 2020 | 4.62 Mn |
| Mar 31, 2020 | 4.92 Mn |
| Dec 31, 2019 | 4.38 Mn |
| Sep 30, 2019 | 6.78 Mn |
| Jun 30, 2019 | 5.16 Mn |
| Mar 31, 2019 | 3.61 Mn |
| Dec 31, 2018 | 2.79 Mn |
| Sep 30, 2018 | 2.43 Mn |
| Jun 30, 2018 | 2.84 Mn |
| Mar 31, 2018 | 3.06 Mn |
| Dec 31, 2017 | 2.39 Mn |
| Sep 30, 2017 | 784,000.00 |
| Jun 30, 2017 | 9.71 Mn |
| Mar 31, 2017 | 3.39 Mn |
| Dec 31, 2016 | 11.89 Mn |
| Sep 30, 2016 | 3.44 Mn |
| Jun 30, 2016 | 3.69 Mn |